Integrated Biopharma (INBP) Operating Income (2010 - 2026)
Integrated Biopharma (INBP) recorded Operating Income of -$869,000 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $589,000 a year earlier.
Powered by 
Analysis
Integrated Biopharma (INBP) Operating Income (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Integrated Biopharma reported Operating Income of -$2.71 million.
- Across earlier fiscal years, Operating Income came in at $2.02 million in FY2025 (+704.8%), $251,000 in FY2024 (+109.2%), $120,000 in FY2023 (-95.6%) and $2.75 million in FY2022 (-52.5%).
- Quarterly Operating Income has ranged from -$1.09 million in fiscal Q3 2026 to $992,000 in fiscal Q3 2022 over the past five years.
- Peak year-over-year performance for Operating Income in the last five years was growth of 706.8% in fiscal Q3 2024, against a decline of 95.6% in fiscal Q3 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -$1.09 million (Q3 2026), -$914,000 (Q2 2026) and $163,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Procter & Gamble | 336.76 Bn | 292.75 Bn | 10.28 Bn | 3.95 Bn |
| 2 | Colgate Palmolive | 67.18 Bn | 62.24 Bn | 3.30 Bn | 1.02 Bn |
| 3 | Estee Lauder Companies | 33.32 Bn | 21.40 Bn | 2.74 Bn | -39.00 Mn |
| 4 | Kenvue | 33.09 Bn | 28.70 Bn | 2.30 Bn | 699.00 Mn |
| 5 | Kimberly Clark | 31.38 Bn | 28.71 Bn | 1.60 Bn | 633.00 Mn |
| 6 | Church & Dwight | 22.37 Bn | 20.90 Bn | 693.90 Mn | 276.40 Mn |
| 7 | Clorox | 9.72 Bn | 8.16 Bn | 804.00 Mn | 474.00 Mn |
| 8 | e.l.f. Beauty | 6.17 Bn | 5.15 Bn | 398.84 Mn | 102.44 Mn |
| 9 | Reynolds Consumer Products | 4.71 Bn | 4.37 Bn | 245.00 Mn | 138.00 Mn |
| 10 | Integrated Biopharma | 5.59 Mn | -14.75 Mn | 28,000.00 | -869,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -869,000.00 |
| Mar 31, 2026 | -1.09 Mn |
| Dec 31, 2025 | -914,000.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 589,000.00 |
| Mar 31, 2025 | 739,000.00 |
| Dec 31, 2024 | 202,000.00 |
| Sep 30, 2024 | 490,000.00 |
| Jun 30, 2024 | 402,000.00 |
| Mar 31, 2024 | 355,000.00 |
| Dec 31, 2023 | -452,000.00 |
| Sep 30, 2023 | -54,000.00 |
| Jun 30, 2023 | 79,000.00 |
| Mar 31, 2023 | 44,000.00 |
| Dec 31, 2022 | -33,000.00 |
| Sep 30, 2022 | 30,000.00 |
| Jun 30, 2022 | 438,000.00 |
| Mar 31, 2022 | 992,000.00 |
| Dec 31, 2021 | 730,000.00 |
| Sep 30, 2021 | 585,000.00 |
API Access
Integrated Biopharma Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=INBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "INBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=INBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();